PL BioScience provides human Platelet Lysate-based 2D and 3D cell culture solutions that serve as a xeno-free alternative to Fetal Bovine Serum, addressing the need for safer and more effective growth environments in research and clinical applications. Their ELAREM™ platform offers various grades of human Platelet Lysate, ensuring compliance with safety standards for diverse applications in regenerative medicine and cellular therapeutics.
Funding
$13M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Fetal Bovine Serum (FBS), a common supplement in cell culture, carries the risk of xeno-contamination and ethical concerns, while also exhibiting batch-to-batch variability that affects experimental reproducibility. Traditional cell culture methods often lack the necessary growth factors and nutrients to mimic the natural cellular environment, hindering optimal cell expansion and performance.
Solution
PL BioScience provides a range of human Platelet Lysate (hPL) products under the ELAREM™ platform, offering a xeno-free alternative to FBS for 2D and 3D cell culture. hPL is derived from human platelets and contains a rich source of growth factors, promoting efficient cell expansion and simulating the natural cell environment. The ELAREM™ platform offers various grades of hPL, including research-grade, GMP-grade, and virus-inactivated options, tailored to meet the safety and performance requirements of diverse applications from basic research to clinical therapeutics. Fibrinogen-depleted options are also available to prevent clotting.
Target Audience
The primary target audience includes researchers in cell biology, regenerative medicine, and tissue engineering, as well as clinicians and companies involved in cell therapy development and manufacturing.
Features
- Xeno-free alternative to Fetal Bovine Serum (FBS), eliminating risks of animal-derived contaminants
- ELAREM™ Prime: Affordable hPL tailored for academic research and diagnostics
- ELAREM™ Perform: hPL product line supporting pre-clinical stem cell therapy research
- ELAREM™ Ultimate: Virus-inactivated hPL for therapeutic applications requiring the highest safety standards
- Fibrinogen-depleted (FD) options to prevent clot formation in cell cultures
- Available in Research Grade, GMP Grade, and GMP-Clinical Grade to suit different application requirements
- Suitable for both 2D and 3D cell culture applications
- ELAREM™ Matrix Kit: hPL-based hydrogel for 3D cell culture and MSC isolation